ADIPOQ and fatty liver disease: Adiponectin, which is usually an anti-obesity adipokine, increases the activity of AO (Pryde et al., 2010), and it is involved in the response to a high-fat diet and the development of fatty liver disease due to ethanol intake (Gamberi et al., 2018).